Randomized Trial of Regorafenib in Combination with Pembrolizumab or Pembrolizumab Monotherapy for Patients with MSI-H Colorectal Cancer

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT06006923

Study Contact: studies@hoosiercancer.org; (317) 921-2050.